Concurrent nuclear ERG and MYC protein overexpression defines a subset of locally advanced prostate cancer: Potential opportunities for synergistic targeted therapeutics-Reference-Cited by-同舟云学术

Concurrent nuclear ERG and MYC protein overexpression defines a subset of locally advanced prostate cancer: Potential opportunities for synergistic targeted therapeutics

Published:2016-03-08 Issue:9 Volume:76 Page:845-853
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Udager Aaron M.¹,DeMarzo Angelo M.²,Shi Yang³⁴,Hicks Jessica L.²,Cao Xuhong⁴,Siddiqui Javed⁴,Jiang Hui³,Chinnaiyan Arul M.¹⁴⁵⁶⁷,Mehra Rohit¹⁴⁶

Affiliation:

1. Department of Pathology; University of Michigan Health System; Ann Arbor Michigan

2. Department of Pathology; The Sidney Kimmel Comprehensive Cancer Center and The James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine; Baltimore Maryland

3. Department of Biostatistics; University of Michigan School of Public Health; Ann Arbor Michigan

4. Michigan Center for Translational Pathology; Ann Arbor Michigan

5. Department of Urology; University of Michigan Health System; Ann Arbor Michigan

6. Comprehensive Cancer Center; University of Michigan Health System; Ann Arbor Michigan

7. Howard Hughes Medical Institute; Ann Arbor Michigan

Funder

Prostate Cancer Foundation

National Cancer Institute Prostate SPORE

Early Detection Research Network

American Cancer Society

A. Alfred Taubman Medical Research Institute

The Howard Hughes Medical Institute